INTEGREX

USPTO USPTO 2002 CANCELLED - SECTION 8

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke INTEGREX wurde als Wortmarke am 06.05.2002 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 29.03.2005 im Markenregister eingetragen. Der aktuelle Status der Marke ist "CANCELLED - SECTION 8".

Markendetails Letztes Update: 20. Mai 2018

Markenform Wortmarke
Aktenzeichen 76406884
Registernummer 2936622
Anmeldedatum 06. Mai 2002
Veröffentlichungsdatum 23. September 2003
Eintragungsdatum 29. März 2005

Markeninhaber

SUITE 950
92868 ORANGE
US

Markenvertreter

Waren und Dienstleistungen

35 MANAGEMENT ASSISTANCE FOR CLINICAL TRIALS OF INVESTIGATIONAL DRUGS, NAMELY, ARRANGING FOR SITES TO PERFORM CLINICAL TRIALS, ARRANGING FOR THE IMPORT, PACKAGING, SHIPPING, LABELING, AND DISTRIBUTION OF DRUGS AND OTHER INVESTIGATIONAL SUPPLIES AND EQUIPMENT TO AND FROM THE CLINICAL TRIAL SITES, ARRANGING FOR THE CENTRAL COLLECTION OF LABORATORY SPECIMENS FROM CLINICAL TRIAL SITES, MAKING ANY AND ALL FILINGS REQUIRED BY THE FOOD AND DRUG ADMINISTRATION FOR INVESTIGATIONAL NEW DRUGS AND NEW DRUG APPLICATIONS, PREPARING STATISTICAL REPORTS RESULTING FROM CLINICAL TRIALS; COOPERATIVE ADVERTISING AND MARKETING OF NEW DRUGS
41 TRAINING CLINICAL TRIAL SITE PERSONNEL CONCERNING DRUG PROTOCOL REQUIREMENTS AND THE USE OF TESTS AND RATING SYSTEMS FOR SUCH PROTOCOL; TRAINING CLINICAL TRIAL PERSONNEL IN THE USE OF MEDICAL AND RESEARCH EQUIPMENT REQUIRED BY DRUG AND/OR DEVICE PROTOCOLS; ARRANGING MEDICAL CONFERENCES AND SYMPOSIA; PROVIDING CONTINUING MEDICAL EDUCATION TO PHYSICIANS AND OTHER HEALTH-CARE PROVIDERS AND ARRANGING AND MANAGING SPEAKERS' BUREAUS IN CONJUNCTION THEREWITH; MEDICAL MANUSCRIPT PREPARATION AND SUBMISSION; DEVELOPMENT AND PUBLICATION OF MEDICAL JOURNALS
42 TECHNICAL WRITING OF CLINICAL TRIAL REPORTS FOR OTHERS; DATABASE DEVELOPMENT SERVICES TO PROCESS DATA COLLECTED FROM CLINICAL TRIALS; PHARMACEUTICAL DRUG DEVELOPMENT SERVICES
44 PROVIDING MEDICAL MONITORING SERVICES, NAMELY REVIEW OF TRAIL DATA REPORTS FOR SAFETY PURPOSES, AND TO DETERMINE AND ASSURE COMPLIANCE WITH CLINICAL STUDY PROTOCOL REQUIREMENTS AS WELL AS COMPLIANCE WITH GOOD CLINICAL PRACTICES AND FOOD AND DRUG ADMINISTRATION AND/OR OTHER REGULATIONS GOVERNING CLINICAL TRIALS
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1376406884